Telehealth app developer ResApp breathes easy on relisting

The company behind an inventive telehealth app ResApp, which allows doctors to diagnose a host of respiratory diseases through a smartphone, is relisting on the ASX today.  The technology, undergoing testing at Joondalup Hospital in Western Australia, allows doctors to diagnose respiratory diseases such as pneumonia, bronchitis and asthma through a cough into a smartphone.  Read more here .